Elevated serum C-reactive protein as a prognostic marker in small cell lung cancer
about
Progression-free survival: an important prognostic marker for long-term survival of small cell lung cancerC-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer.High CRP values predict poor survival in patients with penile cancer.A combined prognostic serum interleukin-8 and interleukin-6 classifier for stage 1 lung cancer in the prostate, lung, colorectal, and ovarian cancer screening trialElevated C-reactive protein values predict nodal metastasis in patients with penile cancerC-reactive protein as a prognostic factor for human osteosarcoma: a meta-analysis and literature review.Is C-reactive protein useful in prognostication for colorectal cancer? A systematic review.Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung CancerC-reactive protein, early life stress, and wellbeing in healthy adultsRetrospective analysis of outcomes and prognostic factors of chemotherapy for small-cell lung cancer.A systemic inflammation-based prognostic scores (mGPS) predicts overall survival of patients with small-cell lung cancer.Do preoperative serum C-reactive protein levels predict the definitive pathological stage in patients with clinically localized prostate cancer?Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application.Oxidative Stress Markers in Tuberculosis and HIV/TB Co-Infection.Glycoprotein nonmetastatic B as a prognostic indicator in small cell lung cancer.High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.High pretreatment serum C-reactive protein level predicts a poor prognosis for combined small-cell lung cancer.Procalcitonin Is Not Useful to Discriminate Between Infectious and Noninfectious CRP Elevation in Patients with Non-Small Cell Lung Cancer.C-Reactive protein: a major inflammatory biomarker
P2860
Q33728681-46BF19B0-281B-4301-B0C4-3ECFEF4BA8AAQ33877471-5EE2621E-A5AF-41DB-8440-C1A0E5D6A2F3Q33994372-EF6D859A-4596-4CE2-AC65-3CC742B9B6EAQ34705218-3132548F-83E3-413C-912B-4A16CBCBAA2EQ34747013-1A53BE5D-5318-4073-A145-80A9AC5914F1Q35024082-7B449341-AF2D-4FA4-B58A-E634AC7A6CBCQ35163616-9AF5B707-6C9D-448C-8B26-F5E493B6A714Q35209326-A75E7106-9B2B-4B51-AC28-149B0245446AQ35754078-415D125C-2FA6-468D-99FC-977089279AC9Q36632190-992822AE-2668-425B-B8F2-6C1F985D56FDQ37643545-FE09FD76-DEFE-4A57-985B-388E4AE1EF42Q39123143-234CC405-30C0-44A6-8180-1FFFCABCC337Q40264726-540C87D7-877E-4939-9354-AD3C89CC9604Q41173805-65D44AD9-1F64-4BE2-8BF4-11CB16101A19Q41926336-CC3DE9E3-CFD9-4B57-BA2F-5BB3AFFB3CE4Q51010443-BADAD728-B58D-44A1-A97F-F84D4AD920E2Q51606684-EA2E1AF9-3FCD-4501-B92E-DB7A495A44D9Q51626805-15F471F0-1F87-44CD-B047-B42129C3F89BQ53733494-4019344D-B47E-4F3A-9C1E-31CF0444F4FAQ57818432-76601CEE-6BC4-4D2E-A99B-1243B559150C
P2860
Elevated serum C-reactive protein as a prognostic marker in small cell lung cancer
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Elevated serum C-reactive protein as a prognostic marker in small cell lung cancer
@ast
Elevated serum C-reactive protein as a prognostic marker in small cell lung cancer
@en
type
label
Elevated serum C-reactive protein as a prognostic marker in small cell lung cancer
@ast
Elevated serum C-reactive protein as a prognostic marker in small cell lung cancer
@en
prefLabel
Elevated serum C-reactive protein as a prognostic marker in small cell lung cancer
@ast
Elevated serum C-reactive protein as a prognostic marker in small cell lung cancer
@en
P2860
P1476
Elevated serum C-reactive protein as a prognostic marker in small cell lung cancer
@en
P2093
Dae Joon Kim
Soojung Hong
P2860
P304
P356
10.3349/YMJ.2012.53.1.111
P577
2012-01-01T00:00:00Z